Skip to main content
. 2020 Nov 16;7:601279. doi: 10.3389/fmed.2020.601279

Table 2.

Comorbidities and number of comorbidities in elderly and nonelderly patients with IPF.

Age group <75 years n = 659 Age group ≥75 years n = 350 p-value
Left heart disease, n (%) 31 (4.7) 36 (10.3) 0.001
Coronary artery disease, n (%) 148 (22.5) 129 (36.9) <0.001
Cerebrovascular diseasea, n (%) 45 (6.8) 28 (8.0) 0.494
Peripheral arterial diseaseb, n (%) 17 (2.6) 19 (5.4) 0.020
Atrial fibrillation, n (%) 37 (5.6) 54 (15.4) <0.001
Deep venous thrombosis, n (%) 13 (2.0) 10 (2.9) 0.370
Pulmonary arterial embolism, n (%) 10 (1.5) 11 (3.1) 0.082
Pulmonary hypertension, n (%) 96 (14.6) 59 (16.9) 0.337
Arterial hypertension, n (%) 332 (50.4) 222 (63.4) <0.001
Diabetes mellitus, n (%) 140 (21.2) 92 (26.3) 0.070
Emphysema, n (%) 65 (9.9) 36 (10.3) 0.832
Lung cancer, n (%) 11 (1.7) 5 (1.4) 0.771
Obstructive sleep apnoea, n (%) 73 (11.1) 29 (8.3) 0.161
Depression/depressive disorder, n (%) 48 (7.3) 9 (2.6) 0.002
Anxiety, n (%) 32 (4.9) 6 (1.7) 0.013
Other comorbid diseases, n (%) 338 (51.3) 189 (54.0) 0.412
Number of comorbidities, mean (sd) 2.8 (2.3) 3.6 (2.5) <0.001
None, n (%) 89 (13.5) 29 (8.3) 0.001
1–3, n (%) 354 (53.7) 165 (47.1)
≥4, n (%) 216 (32.8) 156 (44.6)

Data are presented as mean ± SD, or n (%).

a

Carotid stenosis, stroke.

b

Symptomatic or ankle brachial index <0.8.